Oncology

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the state of cancer treatment and the oncology market

This dossier presents key facts and figures about the global and U.S. cancer treatment situation and the oncology market. This document provides a closer look on the market, on companies, top products, research and development, treatment types, etc.

Table of contents

  • 1. Cancer facts
    • Global death rate - leading causes 2016

    • Cancer deaths worldwide by major type 2016

    • U.S. Americans with a history of cancer living 2004-2016

    • Number of new cancer cases in U.S. from 1999 to 2015

    • Deaths by cancer in the U.S. 1950-2016

  • 2. Oncology market
    • Global oncology costs 2010-2017

    • Expenditure and growth worldwide in oncology market 2012-2022

    • Oncology medicine spending growth 2013-2017, by region

    • Predicted oncology spending in 2022, by region

    • Emerging cancer diagnostics market size by world region 2015 and 2023

    • Oncology therapeutic market growth U.S. 2012-2017, by segment

  • 3. Companies
    • Global oncology revenue by top ten pharmaceutical companies 2017 and 2024

    • Global top pharmaceutical companies by oncology market share 2017 and 2024

    • Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2017

    • Celgene's top product revenues 2012-2017

    • Bristol-Myers Squibb's top products based on revenue 2008-2017

    • U.S. venture investments in oncology companies 2006-2017

    • U.S. oncology company IPO money raised 2006-2017

  • 4. Cancer drugs
    • Top 5 worldwide oncology products by revenue 2017 and 2024

    • Top 5 worldwide oncology products by market share 2017 and 2024

    • Availability of new cancer drugs by country as of 2017

    • Top U.S. oncology products by revenue in 2016

    • Number of cancer drugs by cost and number of patients U.S. 2017

  • 5. Research and development
    • FDA on breakthrough therapy requests by therapy area 2017

    • FDA on breakthrough therapy requests granted by therapy area 2017

    • Distribution of late phase oncology pipeline in 2017 by type

    • Number of cancer drugs in development in the U.S. 2005-2018

    • Time from R&D start to approval of select cancer drugs 2017

    • Total R&D costs including costs of capital for select cancer drugs 2017

  • 6. Immuno-oncology
    • Worldwide top drug producing mechanisms of action by number of active compounds 2018

    • Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action

    • Global cancer immunotherapy market size 2016 and 2022 forecast

    • Global cancer immunotherapy sales share by type 2021 forecast

    • Leading cancer immunotherapy collaborations worldwide by value 2018

  • 7. Treatment types
    • Distribution of treatment types for female breast cancer by stage 2013

    • Distribution of treatment types for prostate cancer 2010-2012

    • Distribution of treatment types for colon cancer by stage 2013

    • Distribution of treatment types for lung cancer in the U.S. 2013

    • Distribution of treatment types for non-Hodgkin lymphoma 2013

  • 8. Physicians and patients
    • Number of oncologists per one million people by select country 2018

    • Number of active physicians in the U.S. 2018 by specialty area

    • Number of hours U.S. oncologists spend a week seeing patients 2018

    • Number of minutes U.S. oncologists spend with each patient 2018

    • Cancer patients using medication in select countries 2018

    • Cancer sufferers based on lifestyle habits by select country 2018

    • Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016

    • Patients whose tumors are driven by genetic mutations by cancer type 2016

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

News
News